PRELID2 and hepatocellular carcinoma: In addition, HCC patients with high expression of PRELID2 had a shorter lifespan than patients with low expression of PRELID2 (P < 0.001), in contrast, PRELID1 was not correlated with a poor prognosis in HCC patients (P = 0.082, Additional file 1: Fig. S5e).